Using CRISPR gene editing, a team from Children’s Hospital of Philadelphia (CHOP) and Penn Medicine have thwarted a lethal lung disease in an animal model in which a harmful mutation causes death within hours after birth.
This proof-of-concept study, published today in Science Translational Medicine, showed that in uteroediting could be a promising new approach for treating lung diseases before birth.
“The developing fetus has many innate properties that make it an attractive recipient for therapeutic gene editing,” said study co-leader William H. Peranteau, MD, an investigator at CHOP’s Center for Fetal Research, and a pediatric and fetal surgeon in CHOP’s Center for Fetal Diagnosis and Treatment. “Furthermore, the ability to cure or mitigate a disease via gene editing in mid- to late gestation before birth and the onset of irreversible pathology is very exciting. This is particularly true for diseases that affect the lungs, whose function becomes dramatically more important at the time of birth.”
The lung conditions the team is hoping to solve — congenital diseases such as surfactant protein deficiency, cystic fibrosis, and alpha-1 antitrypsin — are characterized by respiratory failure at birth or chronic lung disease with few options for therapies. About 22 percent of all pediatric hospital admissions are because of respiratory disorders, and congenital causes of respiratory diseases are often lethal, despite advances in care and a deeper understanding of their molecular causes. Because the lung is a barrier organ in direct contact with the outside environment, targeted delivery to correct defective genes is an attractive therapy.
“We wanted to know if this could work at all,” said study co-leader Edward E. Morrisey, PhD, a professor of Cardiovascular Medicine in the Perelman School of Medicine at the University of Pennsylvania. “The trick was how to direct the gene-editing machinery to target cells that line the airways of the lungs.”
The researchers showed that precisely timed in utero delivery of CRISPR gene-editing reagents to the amniotic fluid during fetal development resulted in targeted changes in the lungs of mice. They introduced the gene editors into developing mice four days before birth, which is analogous to the third trimester in humans.
The cells that showed the highest percentage of editing were alveolar epithelial cells and airway secretory cells lining lung airways. In 2018, a team led by Morrisey identified the alveolar epithelial progenitor (AEP) lineage, which is embedded in a larger population of cells called alveolar type 2 cells. These cells generate pulmonary surfactant, which reduces surface tension in the lungs and keeps them from collapsing with every breath. AEPs are a stable cell type in the lung and turn over very slowly, but replicate rapidly after injury to regenerate the lining of the alveoli and restore gas exchange.
In a second experiment, the researchers used prenatal gene editing to reduce the severity of an interstitial lung disease, surfactant protein C (SFTPC) deficiency, in a mouse model that has a common disease-causing mutation found in the human SFTPC gene. One hundred percent of untreated mice with this mutation die from respiratory failure within hours of birth. In contrast, prenatal gene editing to inactivate the mutant Sftpc gene resulted in improved lung morphology and survival of over 22 percent of the animals.
Future studies will be directed toward increasing the efficiency of the gene editing in the epithelial lining of lungs as well as evaluating different mechanisms to deliver gene editing technology to lungs. “Different gene editing techniques are also being explored that may one day be able to correct the exact mutations observed in genetic lung diseases in infants,” Morrisey said.
The Latest on: Gene editing
via Google News
The Latest on: Gene editing
- Brainstorm Health: CRISPR V. Superbugs, Gottlieb to NEA, UniQure Gene Therapy on May 22, 2019 at 4:08 pm
NPR has a fun, fascinating piece out on an issue near and dear to our hearts here at Brainstorm Health – the role that gene editing could play in fighting the antibiotic-resistant superbug crisis. ... […]
- University of California Will Test New Gene Editing Tools on May 22, 2019 at 2:24 pm
(TNS) — Primate researchers at the University of California, Davis, will be testing the safety and efficacy of gene editing tools that they expect will have future applications in humans, work that ... […]
- He Jiankui Research Prompts U.S. Academies, U.K. Society to Create Germline Editing Commission on May 22, 2019 at 12:00 pm
During the Summit, He detailed his rationale, screening, and regulatory procedures that led to the birth of the twins, who had received genome editing of the CCR5 gene in the hopes of preventing HIV ... […]
- Newly discovered molecules safely halt the gene editing process on May 22, 2019 at 6:02 am
Two non-toxic molecules that could allow scientists to have better control over CRISPR gene editing have been identified. Researchers say that the molecules could halt the gene editing process within ... […]
- Regulations would stifle innovation of gene-edited food production, geneticists say on May 21, 2019 at 6:50 pm
“I share your concern,” Mr. Ibach said. “I think gene-editing offers a great opportunity to address some of the consumer concerns that we have.” Supporters of the technology dismiss worries over ... […]
- China set to impose regulations on gene-editing following controversial trial with human embryos on May 21, 2019 at 5:23 am
After global backlash involving the use of gene-editing tool CRISPR on human embryos, China will further tighten regulation on manipulating the human genome. According to a report in Nature, a draft ... […]
- Briefing: China’s new civil code draft adds regulations for human gene editing on May 20, 2019 at 7:34 pm
What happened: The most recent draft of China’s updated civil code includes new regulations protecting human genes in adults or embryos from experimentation that could “endanger human health or ... […]
- China set to introduce gene-editing regulation following CRISPR-baby furore on May 20, 2019 at 1:22 am
China is poised to introduce a new regulation on gene editing in humans. A draft of the country’s new civil code lists human genes and embryos in a section on personality rights to be protected. ... […]
- Researchers use gene editing to make cells immune to HIV and other infections in Fred Hutch study on May 17, 2019 at 7:00 pm
HIV infects a human cell. (National Institute of Health Photo) Some viruses, no matter how hard we try, remain resistant to vaccines. Now, researchers are using a different method, gene editing, as a ... […]
- Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself on May 14, 2019 at 3:04 am
W hen Rachel Haurwitz started her biology Ph.D. at the University of California, Berkeley, the award-winning biochemist Jennifer Doudna suggested Haurwitz investigate part of a bacterial immune system ... […]
via Bing News